1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Uzbekistan Pharmaceuticals and Healthcare Report Q4 2015

Uzbekistan Pharmaceuticals and Healthcare Report Q4 2015

  • October 2015
  • -
  • Business Monitor International
  • -
  • 93 pages

Includes 3 FREE quarterly updates

BMI View: Pharmaceutical sales in Uzbekistan will continue to expand over the forecast period, creatingopportunities for drugmakers. Meanwhile, the Uzbek government will continue to improve the domesticbusiness environment through regulatory developments, privatisation and the promotion of foreign directinvestment, which will benefit investments that enhance drug manufacturing and operations in the country.However, the regional economic slowdown and a challenging operating environment will continue to weighon Uzbekistan's pharmaceutical and healthcare sector growth potential, keeping a lid on its attractivenessto investors.

In Q415 we have revised downwards Uzbekistan's Pharmaceuticals RRI score to 38.2 from 40.2 in theprevious quarter, out of the maximum 100 points. The score revision was due to a slight moderation inmarket expenditure indices. Uzbekistan's score is driven by demographic growth (population growth scoreof 3.0 out of 5) and the expanding pharmaceutical market (sector value growth score of 8.4 out of 12) butdragged down by a small market size (market expenditure score of 4.0 out of 12) and low spending percapita on medicines (spending per capita score of 2.4 out of 12).

Table Of Contents

Uzbekistan Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Operational Risk SWOT 11
Industry Forecast 13
Pharmaceutical Market Forecast 13
Table: Pharmaceutical Sales, Historical Data And Forecasts (Uzbekistan 2011-2019) 14
Healthcare Market Forecast 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2011-2019) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2011-2019) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2011-2019) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2011-2019) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2011-2019) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2011-2019) 24
OTC Medicines Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Uzbekistan 2011-2019) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Uzbekistan 2013-2019) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Uzbekistan 2013-2019) 30
Key Risks To BMI's Forecast Scenario 31
Macroeconomic Forecasts 32
Economic Analysis 32
Table: Economic Activity (Uzbekistan 2010-2019) 35
Industry Risk Reward Index 36
Central And Eastern Europe Risk/Reward Index - Q4 2015 36
Uzbekistan Risk/Reward Index 42
Rewards 42
Risks 43
Market Overview 44
Industry Trends And Developments 46
Epidemiology 46
Healthcare Sector 48
Healthcare Provision 50
Health Insurance Sector 51
Healthcare Sector Reforms 53
Research And Development 54
Clinical Trials 54
International Cooperation 55
Regulatory Development 58
Counterfeit Drugs 59
Intellectual Property Rights 60
Pricing And Reimbursement 61
Competitive Landscape 63
Research-Based Industry 64
Generic Drugmakers 64
Leading Domestic Players 66
Table: List Of Companies In Uzpharmsanoat SJSC (as of October 7 2013) 66
Pharmaceutical Sector Reforms 68
Foreign Pharmaceutical Industry 68
Recent Pharmaceutical Industry Developments 70
Pharmaceutical Wholesale 70
Pharmaceutical Retail 71
Company Profile 72
Jurabek Laboratories 72
Uzpharmsanoat 76
Asklepiy Pharmaceutical Company 80
Demographic Forecast 82
Table: Population Headline Indicators (Uzbekistan 1990-2025) 83
Table: Key Population Ratios (Uzbekistan 1990-2025) 83
Table: Urban/Rural Population and Life Expectancy (Uzbekistan 1990-2025) 84
Table: Population By Age Group (Uzbekistan 1990-2025) 84
Table: Population By Age Group % (Uzbekistan 1990-2025) 85
Glossary 87
Methodology 89
Pharmaceutical Expenditure Forecast Model 89
Healthcare Expenditure Forecast Model 89
Notes On Methodology 90
Risk/Reward Index Methodology 91
Index Overview 92
Table: Pharmaceutical Risk/Reward Index Indicators 92
Indicator Weightings 93

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.